Independently ligating CD38 and FcγRIIB relays a dominant negative signal to B cells

Hybridoma

Volumn 18, Issue 2, 1999, Pages 113-119

  Oliver, Alyce M ^a   Grimaldi, J Christopher ^b   Howard, Maureen C ^b   Kearney, John F ^a,c  

^a University of Alabama at Birmingham   (United States)

^b MERCK RESEARCH LABORATORIES   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DIPHOSPHATE; CD38 ANTIGEN; IMMUNOGLOBULIN FC FRAGMENT; INTERLEUKIN 4; LIPOPOLYSACCHARIDE; MONOCLONAL ANTIBODY; NICOTINAMIDE ADENINE DINUCLEOTIDE; RIBOSE;

ANIMAL EXPERIMENT; ANTIGEN EXPRESSION; ARTICLE; B LYMPHOCYTE; CELL ACTIVATION; CELL DIFFERENTIATION; CELL LINE; CELL PROLIFERATION; CLONING; CROSS LINKING; ENZYME ACTIVITY; HEMATOPOIETIC CELL; MOUSE; NONHUMAN; PLASMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

ANIMALIA;

EID: 0033033477     PISSN: 0272457X     EISSN: None     Source Type: Journal    
DOI: 10.1089/hyb.1999.18.113     Document Type: Article

References (32)

1. Oliver AM, Martin F, and Kearney JF: Mouse CD38 is down-regulated on germinal center B cells and mature plasma cells. J Immunol 1997;158:1108-1115.
2. Howard M, Grimaldi JC, Bazan JF, Lund FE, Santos-Argumedo L, Parkhouse RME, Walseth TF, and Lee HC: Formation and hydrolysis of cyclic ADP-ribose catalyzed by lymphocyte antigen CD38. Science 1993;262:1056-1059.
3. Santos-Argumedo L, Teixeira C, Preece G, Kirkham PA, and Parkhouse RME: A B lymphocyte surface molecule mediating activation and protection from apoptosis via calcium channels. J Immunol 1993;151:3119-3130.
4. Harada N, Santos-Argumedo L, Chang R, Grimaldi JC, Lund FE, Brannan CI, Copeland NG, Jenkins NA, Heath AW, Parkhouse RME, et al.: Expression cloning of a cDNA encoding a novel murine B cell activation marker. J Immunol 1993;151:3111-3118.
5. Liu Y and Banchereau J: The paths and molecular controls of peripheral B-cell development. The Immunologist 1996;4:55.
6. Kikuchi Y, Yasue T, Miyake K, Kimoto M, and Takatsu K: CD38 ligation induces tyrosine phophorylation of Bruton tyrosine kinase and enhanced expression of interleukin 5-receptor α chain: Synergistic effects with interleukin 5. Proc Natl Acad Sci USA 1995;92:11814-11818.
7. Hamann A, Jablonski-Westrich D, Jonas P, and Thiele H: Homing receptors reexamined: Mouse LECAM-1 (MEL-14 antigen) is involved in lymphocyte migration into gut-associated lymphoid tissue. Eur J Immunol 1991;21:2925-2929.
8. Oliver AM, Martin F, Gartland GL, Carter RH, and Kearney JF: Marginal zone B cells exhibit unique activation, proliferative and immunoglobulin secretory responses. Eur J Immunol 1997; 27:2366-2374.
9. Lund FE, Yu N, Kim K, Reth M, and Howard MC: Signaling through CD38 augments B cell antigen receptor (BCR) responses and is dependent on BCR expression. J Immunol 1996;157:1455-1467.
10. Sidman CL and Unanue ER: Requirements for mitogenic stimulation of murine B cells by soluble anti-IgM antibodies. J Immunol 1979;122:406-413.
11. Dickler HB and Kubicek MT: Effects of various forms of monoclonal anti-FcγR II (2.4G2) on B lymphocyte responses. Mol Immunol 1998;25:1169-1174.
12. Ryan JL and Henkart PA: Fc Receptor-mediated inhibition of murine B-lymphocyte activation. J Exp Med 1976;144:768-775.
13. Amigorena S, Bonnerot C, Drake JR, Choquet D, Hunziker W, Guillet J, Webster P, Sautes C, Mellman I, and Fridman WH: Cytoplasmic domain heterogeneity and functions of IgG Fc receptors in B lymphocytes. Science 1992;256:1808-1812.
14. Takai T, Ono M, Hikida M, Ohmori H, and Ravetch JV: Augmented humoral and anaphylactic responses in FcγRII-deficient mice. Nature 1996;379:346-349.
15. Klaus GGB, Hawrylowicz CM, Holman M, and Keeler KD: Activation and proliferation signals in mouse B cells III. Intact (IgG) anti-immunoglobulin antibodies activate B cells but inhibit induction of DNA synthesis. Immunology 1984;53:693-701.
16. Phillips NE and Parker DC: Fc-dependent inhibition of mouse B cell activation by whole anti-μ, antibodies. J Immunol 1983; 130:602-606.
17. Phillips NE and Parker DC: Cross-linking of B lymphocyte Fcγ receptors and membrane immunoglobulin inhibits anti-immunoglobulin-induced blastogenesis. J Immunol 1984;132:627-632.
18. Phillips NE and Parker DC: Subclass specificity of Fcγ receptor-mediated inhibition of mouse B cell activation. J Immunol 1985;134:2835-2838.
19. O'Garra A, Rigley KP, Holman M, McLaughlin JB, and Klaus GGB: B-cell-stimulatory factor 1 reverses Fc receptor-mediated inhibition of B-lymphocyte activation. Proc Natl Acad Sci USA 1987;84:6254-6258.
20. D'Ambrosio D, Hippen KL, Minskoff SA, Mellman I, Pani G, Siminovitch KA, and Cambier JC: Recruitment and activation of PTP1C in negative regulation of antigen receptor signaling by FcγRIIB1. Science 1995;268:293-297.
21. Cambier JC: Antigen and Fc receptor signaling. J Immunol 1995;3281-3285.
22. Ono M, Bolland S, Tempst P, and Ravetch J: Role of the inositol phosphatase SHIP in negative regulation of the immune system by the receptor FcγRIIB. Nature 1996;383:263-266.
23. Ono M, Okada H, Bolland S, Yanagi S, Kurosaki T, and Ravetch JV: Deletion of SHIP or SHP-1 reveals two distinct pathways for inhibitory signaling. Cell 1997;90:293-301.
24. Chacko GW, Tridandapani S, Damen J, Liu L, Krystal G, and Coggeshall KM: Negative signaling in B lymphocytes induces tyrosine phosphorylation of the 145-kDa inositol polyphosphate 5-phosphatase, SHIP. J Immunol 1996;157:2234-2238.
25. Tridandapani S, Kelley T, Pradhan M, Cooney D, Justement LB, and Coggeshall KM: Recruitment and phosphorylation of SH2-containing inositol phosphatase and she to the B-cell Fcγ immunoreceptor tyrosine-base inhibition motif peptide motif. Mol Cell Biol 1997;17:4305-4311.
26. Itoh N, Yonehara S, Schreurs J, Gorman D, Maruyama K, Ishii A, Yahara I, Arai K, and Miyajima A: Cloning of an interleukin-3 receptor gene: A member of a distinct receptor gene family. Science 1990;247:324-327.
27. Jones B, Tite JP, and Janeway CA Jr: Different phenotypic variants of the mouse B cell tumor A20/2J are selected by antigen- and mitogen-triggered cytotoxicity of L3T4-positive, I-A restricted T cell clones. J Immunol 1986;136:348-356.
28. Lund FE, Solvason NW, Cooke MP, Heath AW, Grimaldi JC, Parkhouse RME, Goodnow C, and Howard MC: Signaling through murine CD38 is impaired in antigen receptor-unresponsive B cells. Eur J Immunol 1995;25:1338-1345.
29. Lund F, Solvason N, Grimaldi JC, Parkhouse RM, and Howard M: Murine CD38: An immunoregulatory ectoenzyme. Immunol Today 1995;16:463-473.
30. Santos-Argumedo L, Lund FE, Heath AW, Solvason N, Wu WW, Grimaldi JC, Parkhouse RME, and Howard M: CD38 unresponsiveness of xid B cell implicates bruton's tyrosine kinase (btk) as a regulator of CD38 induced signal transduction. Int Immunol 1995;7:163-170.
31. Yamashita Y, Miyake K, Kikuchi Y, Takatsu K, Noda S, Kosugi A, and Kimoto M: A monoclonal antibody against a murine CD38 homologue delivers a signal to B cells for prolongation of survival and protection against apoptosis in vitro: Unresponsiveness of x-linked immunodeficient B cells. Immunology 1995;85:248-255.
32. Muta T, Kurosaki T, Misulovin Z, Sanchez M, Nussenzweig MC, and Ravetch JV: A 13-amino-acid motif in the cytoplasmic domain of FcγRIIb modulates B-cell receptor signaling. Nature 1994; 368:70-73.